Kura Oncology (KURA) Other Operating Expenses (2014 - 2026)

Kura Oncology (KURA) posted quarterly Other Operating Expenses of $262000.0 for Q1 2026, down 98.42% quarter-over-quarter from $16.6 million in Q4 2018.

Kura Oncology (KURA) Other Operating Expenses (2014 - 2026) Analysis & Trends

Kura Oncology (KURA) has reported Other Operating Expenses for 6 consecutive years, with $262000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Operating Expenses changed N/A year-over-year to $262000.0; the TTM figure through Mar 2026 stood at $262000.0 (changed N/A YoY), while the FY2025 annual figure was $57000.0, changed N/A from the prior year.
  • Other Operating Expenses declined to $262000.0 in Q1 2026 per KURA's latest filing, from $16.6 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $262000.0 in Q1 2026 and bottomed at $262000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Kura Oncology 966.11 Mn 966.11 Mn 20.63 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 243,000.00
Mar 31, 2026 262,000.00
Dec 31, 2018 16.63 Mn
Sep 30, 2018 15.98 Mn
Jun 30, 2018 15.28 Mn
Mar 31, 2018 14.99 Mn
Dec 31, 2017 11.00 Mn
Sep 30, 2017 9.50 Mn
Jun 30, 2017 7.93 Mn
Mar 31, 2017 7.65 Mn
Dec 31, 2016 7.48 Mn
Sep 30, 2016 7.06 Mn
Jun 30, 2016 5.79 Mn
Mar 31, 2016 5.84 Mn
Dec 31, 2015 15.53 Mn
Sep 30, 2015 1.01 Mn
Jun 30, 2015 3.32 Mn
Mar 31, 2015 2.55 Mn
Dec 31, 2014 3.79 Mn